The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-yearly Report

14 Sep 2009 16:39

Analyst Investment Management Plc Registration Number 3687441 Interim Unaudited Financial Statements for the 6 Months Ended 31st May 2009 Contents PageDirectors' Statement 3Profit and Loss Account 4Balance Sheet 5

Directors' Statement on the Unaudited Interim Results for the Six Months Ended 31st May 2009

The Company made a profit of 11,697 which compares to a loss of 26,236 in the same period last year. Fee income was 77,358 (2008: 16,976) which reflects performance-related fees earned for the year ended 30 November 2008.

In the first 6 months of the year the return on the funds under management has been 1.25% versus a return of 8.22% on the FTSE All Share Index. The performance of the Open Ended Investment Company (OEIC), quoted as CF Analyst UK Fund since launch date, 1, December 2005 has been minus 8.85% versus a minus 6.46% on the FTSE All Share Index.

The fund had assets of 3.93m on the 31 May 2009. The fund maintains a high cash balance and hence the main reason for the outperformance since inception compared to the index.

We have deliberately not participated in the equity markets and kept more than 50% of the funds under management in cash primarily due to intense volatility, adverse economic climate and uncertainty with regards to the banking sector.

There has been a small increase in costs, but these are still below the level of the comparable period two years ago. The opportunity to cut costs further is limited. It is expected, however, that certain administrative fees will be reduced shortly and the cost savings will be reflected in the next financial year.

The future success of the business is reliant on increasing revenues. Discussions are continuing with a number of parties aimed at increasing revenues.

This Statement has been prepared by and is the sole responsibility of the directors of Analyst Investment Management plc.

CHAIRMAN FINANCE DIRECTORBharat Amin Surbjit Chadda14 September 2009

Analyst Investment Management Plc

Profit And Loss Account

For The Six Months Ended 31 May 2009

Unaudited Unaudited Audited Six Months Six Months 12 months ended ended ended May 2009 May 2008 Nov 2008 GBP GBP GBPTurnover 77,358 16,976 41,160Cost of sales (17,895) (16,581) (36,738) ______ ______ ______Gross profit 59,463 395 4,422Administrative expenses (48,567) (42,012) (97,821) ______ ______ ______Operating profit/(loss) 10,896 (41,617) (93,399)

Other interest receivable and similar income 801 15,381 27,747

______ ______ ______Profit/(loss) on ordinary activities before taxation 11,697 (26,236) (65,652)Taxation 0 0 0 ______ ______ ______Profit/(loss) on ordinary activities after taxation 11,697 (26,236) (65,652) ______ ______ ______Earnings per share (pence) 0.16 (0.36) (0.890) ______ ______ ______

The turnover for the 6 months to 31 May 2009 includes the performance fee of 58,724 earned in the year to 30 November 2008.

The earnings per share are based on the profit after taxation of 11,697, (2008: (26,236)), and the weighted average number of ordinary 2.5 pence shares in issue during the period of 7,377,777 shares, (2007: 7,377,777 shares). Ordinary 2.5 pence shares in issue at 31st May 2009 were 7,377,777.

Analyst Investment Management Plc

Balance SheetAs at 31 May 2009 Unaudited Unaudited Audited as at 31 as at 31 as at May 2009 May 2008 November 2008 GBP GBP GBPFixed assetsTangible assets 0 0 0 ______ ______ ______Current assetsDebtors 11,532 0 12,025Cash at bank and in hand 503,820 547,408 496,862 ______ ______ ______ 515,352 547,408 508,887Creditors: amounts fallingdue within one year - (4,337) (5,232) ______ ______ ______Net Current Assets 515,352 543,071 503,655 ______ ______ ______Net Assets 515,352 543,071 503,655 ______ ______ ______Capital and reservesCalled up share capital 184,444 184,444 184,444Share premium account 1,100,642 1,100,642 1,100,642Profit and loss account (769,734) (742,015) (781,431) ______ ______ ______Equity Shareholders' Funds 515,352 543,071 503,655 ______ ______ ______

vendor
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.